Is Madison Square Garden Sports Corp (MSGS) a risky stock?
As of July 27, 2026, Clavix grades Madison Square Garden Sports Corp (MSGS) B- for risk, a composite score of 70 out of 100 on an A+ to F scale, which puts MSGS in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
The five risk dimensions behind MSGS's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how MSGS scores on each, as of July 27, 2026.
What's moving MSGS's risk right now
Company-specific signals Clavix flags behind MSGS's current grade, drawn from recent news and filings as of July 27, 2026.
The transition signals a generational succession at one of MSGS's marquee sports assets while preserving family control, which may reassure investors about long-term governance co…
Progress toward a peace deal with Iran outweighed hawkish undertones from Fed Chair Kevin Warsh. Plus, the Knicks’ market impact.
MSGS shares may be entering a new valuation regime where the market no longer applies a discount to Dolan-controlled entities, potentially unlocking higher multiples tied to the K…
Recent MSGS news
The latest headlines Clavix ingested for Madison Square Garden Sports Corp, newest first. These feed the news-sentiment dimension of MSGS's grade.
-
Ariel Investments has identified Madison Square Garden Sports Corp. (MSGS) as a top stock to buy, driven by Knicks success. Susquehanna reiterated a Positive rating and raised its price target to $430, implying upside from the current price of approximately $403.
-
Madison Square Garden Sports Corp announced that James Dolan is stepping back from day-to-day management of the New York Rangers, promoting his son Quentin to president and chief operating officer of the team.
What a B- grade means
On the Clavix A+ to F scale, MSGS's composite of 70 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell MSGS or any security. Grades are risk indicators, not predictions of return. Data may be delayed.